Our co-founder Christina Jackson is one of a panel of industry experts discussing the barriers pharmaceutical companies can benefit from addressing. Her takeaway advice? Pharma needs to take more risks in being transparent with patients.
‘From my experience, pharma is often reluctant to fully acknowledge patients’ concerns about potential side effects due to the risk of eliciting adverse events and a perceived risk of inducing fears,’ she says. ‘However, patients’ fears already exist; a major source of their concern is information about possible side effects in the patient package inserts (PPI). We must help them gain a clearer understanding.’
Read more in PM360 online.